SOUTH SAN FRANCISCO, Calif. — August 28, 2025 — Leads & Copy — Alector, Inc. (Nasdaq: ALEC) will participate in investor conferences next month, including the Cantor Global Healthcare Conference on September 4, the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, and the H.C. Wainwright 27th Annual Global Investment Conference on September 9.
Webcasts of the presentations will be available on the “Events & Presentations” page within the Investors section of Alector’s website. Replays will be available for 90 days following the presentation dates.
Alector is focused on developing therapies to counteract neurodegenerative diseases, advancing programs to remove toxic proteins, replace deficient proteins, and restore immune and nerve cell function.
Katie Hogan, Alector, 202-549-0557, katie.hogan@alector.com; David Rosen, Argot Partners (media), 646-461-6387, alector@argotpartners.com; Laura Perry, Argot Partners (investors), 212-600-1902, alector@argotpartners.com
Source: Alector
